Multiple Assemblies exist for SMTL entry 5kot
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor; X-RAY DIFFRACTION 2.10 Å

	SMTL ID 5kot.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 1-(4-methoxybutyl)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]benzimidazole-2-carboxamide; TRIETHYLENE GLYCOL; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE Polypeptides Renin Oligo-state monomer
	SMTL ID 5kot.2 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 1-(4-methoxybutyl)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]benzimidazole-2-carboxamide; TRIETHYLENE GLYCOL; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE Polypeptides Renin Oligo-state monomer
	SMTL ID 5kot.3 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose; 1-(4-methoxybutyl)-~{N}-(2-methylpropyl)-~{N}-[(3~{S},5~{R})-5-morpholin-4-ylcarbonylpiperidin-3-yl]benzimidazole-2-carboxamide; TRIETHYLENE GLYCOL; DI(HYDROXYETHYL)ETHER; DIMETHYL SULFOXIDE Polypeptides Renin Oligo-state homo-hexamer